NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NICHD E-185-2020-0-US-03 Multidimensional MRI Signature For Specific Detection Of Traumatic Brain Injury In Vivo US National Stage 18/019,725 12343132 Issued PDF
NEI E-004-2017-0-JP-01 3D VASCULARIZED HUMAN OCULAR TISSUE FOR CELL THERAPY AND DRUG DISCOVERY JP DIV 2023-015034 Issued
NCI E-165-2020-0-AU-01 HLA Class-II Restricted DRB T-cell Receptors Against RAS with G12D Mutation AU National Stage 2021310213 Pending
NCATS E-147-2022-1-PC-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF PCT PCT PCT/US2023/061824 Expired
NCATS E-112-2023-0-US-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/482,736 Expired
NEI E-005-2023-0-US-01 Deep Learning to Detect Retinal Vasculitis on Color Fundus Photos of Patients with Uveitis US 63/482,676 Expired
NINDS E-074-2023-0-US-01 Methods of Diagnosing and Treating Multiple Sclerosis US 63/482,714 Expired
NIAID E-241-2014-0-US-02 RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 1 (HPIV1) EXPRESSING A CHIMERIC RSV/HPIV1 F PROTEIN AND USES THEREOF US CON 18/162,530 12018051 Issued PDF
NCATS E-218-2021-0-PC-01 FUSED DIAZEPINES AS AGONISTS OF THE INSULIN-LIKE 3 (INSL3) PEPTIDE RECEPTOR RXFP2 AND METHODS OF USE THEREOF PCT PCT PCT/US2023/012013 Expired
NINDS E-120-2020-2-EP-03 ADAPTABLE DUAL-TUNED OPTICALLY CONTROLLED ON-COIL AMPLIFIER FOR HIGH-FIELD MAGNETIC RESONANCE IMAGING SYSTEMS EP National Stage 21746288.6 Issued
NINDS E-120-2020-2-GB-01 ADAPTABLE DUAL-TUNED OPTICALLY CONTROLLED ON-COIL AMPLIFIER FOR HIGH-FIELD MAGNETIC RESONANCE IMAGING SYSTEMS GB EP 21746288.6 Issued
NINDS E-120-2020-2-NL-01 ADAPTABLE DUAL-TUNED OPTICALLY CONTROLLED ON-COIL AMPLIFIER FOR HIGH-FIELD MAGNETIC RESONANCE IMAGING SYSTEMS NL EP 21746288.6 Issued
NINDS E-120-2020-2-FR-01 ADAPTABLE DUAL-TUNED OPTICALLY CONTROLLED ON-COIL AMPLIFIER FOR HIGH-FIELD MAGNETIC RESONANCE IMAGING SYSTEMS FR EP 21746288.6 Issued
NINDS E-120-2020-2-DE-01 ADAPTABLE DUAL-TUNED OPTICALLY CONTROLLED ON-COIL AMPLIFIER FOR HIGH-FIELD MAGNETIC RESONANCE IMAGING SYSTEMS DE EP 21746288.6 Issued
NCATS E-232-2020-0-US-02 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US National Stage 18/018,742 Abandoned
NCI E-196-2018-0-US-02 INSERT FOR PREPARING CELL CULTURE CHAMBERS US National Stage 18/018,762 Pending
NIAID E-001-2024-0-US-05 Viral Strain Serology Assays US 63/482,083 Expired
NIAID E-178-2022-0-US-01 EPSTEIN-BARR VIRUS GLYCOPROTEIN 42 IMMUNOGENS FOR VACCINATION AND ANTIBODY DISCOVERY US 63/482,143 Expired
NHLBI E-191-2020-0-CN-03 SYSTEMS AND METHODS FOR MITRAL VALVE REPLACEMENT CN National Stage 202180059611.1 Pending
NCATS E-232-2020-0-JP-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF JP National Stage 2023-506197 Abandoned
NHLBI E-035-2022-0-PCT-02 PREPARATION OF ISOTOPICALLY LABELED KETOGLUTARATES AND METHODS OF HYPERPOLARIZATION THROUGH SIGNAL AMPLIFICATION BY REVERSIBLE EXCHANGE (SABRE) PCT PCT PCT/US2023/011640 Expired
NCI E-018-2023-0-US-01 METHODS OF DETECTING T CELL RECEPTOR CROSS-REACTIVITY US 63/481,757 Expired
CC E-048-2023-0-US-01 Computer-vision method for bronchoscope navigation referencing and 3D model registration US 63/481,689 Expired
NCI E-199-2022-0-US-01 HUMAN PAPILLOMAVIRUS AND VARICELLA-ZOSTER VACCINE ANTIGENS AND USES
THEREOF IN CANCER IMMUNOTHERAPY 		US 63/481,544 Expired
NCI E-184-2009-0-US-04 Combination Immunotherapy Compositions And Methods US CON 18/158,800 12076382 Issued PDF
NIAID E-197-2023-1-US-03 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] US 63/481,368 Expired
NICHD E-170-2020-0-US-03 TIME EFFICIENT MULTI-PULSED FIELD GRADIENT (MPFG) MRI WITHOUT CONCOMITANT GRADIENT FIELD ARTIFACTS US National Stage 18/017,150 12493092 Issued PDF
NHLBI E-191-2020-0-US-06 SYSTEMS AND METHODS FOR MITRAL VALVE REPLACEMENT US National Stage 18/006,331 Pending
NIA E-024-2022-0-PC-01 GINGERENONE A PRODRUGS AS SENOTHERAPEUTICS AND METHODS OF USE PCT PCT PCT/US2023/010962 Expired
NHLBI E-191-2020-0-EP-04 SYSTEMS AND METHODS FOR MITRAL VALVE REPLACEMENT EP National Stage 21845838.8 Pending
NCI E-172-2020-0-JP-01 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION JP National Stage 2023-503124 Pending
NIAID E-251-2016-0-US-05 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY, HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE US DIV 18/154,745 12168802 Issued PDF
NCI E-045-2022-0-PCT-02 Method of HLA loss Heterozygosity Detection in Liquid Biopsies PCT PCT PCT/US2023/060664 Expired
NEI E-203-2023-0-US-01 APPARATUS AND METHOD FOR EXTRACELLULAR IMPEDANCE SPECTROSCOPY OF EPITHELIA US 63/479,798 Expired
NINDS E-047-2023-0-US-01 Genetic control of MRI signal US 63/479,835 Expired
NCI E-058-2023-0-US-01 BICYCLIC CARBAMOYL PYRIDONE-BASED INTEGRASE STRAND TRANSFER INHIBITORS US 63/438,994 Expired
NCI E-165-2020-0-US-02 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION US National Stage 18/015,776 Pending
NCI E-172-2020-0-US-02 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US National Stage 18/015,781 Pending
NIAID E-104-2020-0-CN-05 RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS CN National Stage 202180061234.5 Pending
NCI E-165-2020-0-JP-01 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12D
MUTATION 		JP National Stage 2023-502572 Pending
NINDS E-130-2022-3-JP-02 OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE JP DIV 2023-003205 Pending
NCI E-176-2022-0-HK-01 ALVELESTAT FOR USE IN THE TREATMENT OF GRAFT REJECTION, BRONCHIOLITIS OBLITERANS SYNDROME AND GRAFT VERSUS HOST DISEASE HK EP 62023066863.9 Abandoned
NCI E-172-2020-0-AU-01 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION AU National Stage 2021309958 Pending
NCATS E-113-2023-1-US-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/479,421 Abandoned
NCI E-051-2022-0-PCT-02 Predicting Patient Treatment Response and Resistance via Single-Cell Transcriptomics of their Tumors PCT PCT PCT/US2023/060416 Expired
NIBIB E-040-2023-0-US-01 INTUBATION SYSTEM AND CHAMBER TANK US 63/438,197 Expired
NCI E-172-2020-0-CA-01 HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation CA National Stage 3185483 Pending
NHLBI E-206-2020-0-US-02 DEVICES AND METHODS FOR CERCLAGE OF LUMENAL SYSTEMS US CON 18/151,601 Pending
NHLBI E-011-2016-0-US-01 CLOSED-ENDED, LINEAR, DUPLEX ADENOASSOCIATED VIRUS DNA, AND USES THEREOF US CON 18/151,803 Abandoned
NIDDK E-032-2023-0-US-01 Sidechain Functionalized S-acylbenzamides With Anti-HIV Activity US 63/437,868 Expired